Hims & Hers : HIMS

All Hims & Hers Articles

46 Articles

Rich Duprey | Jun 22, 2025 at 10:31 AM EDT

3 Stocks to 3X in 3 Years

The Power of Long-Term Investing Long-term investing is the cornerstone of wealth creation, prioritizing steady growth over fleeting market spikes.…

Omor Ibne Ehsan | May 22, 2025 at 10:10 AM EDT

3 Overlooked Dividend Growers With 10%+ Annual Dividend Increases

Investors usually focus on stocks that already have stellar dividend yields, but your portfolio could also benefit from dividend growers.…

Chris MacDonald | May 16, 2025 at 11:03 AM EDT

Buy Amazon (AMZN), Shopify (SHOP) and Hims & Hers (HIMS) in May And Hold Forever

There’s a well-known saying in the investing world, which advises investors to “sell in May and go away.” Historically, that…

Joel South | May 5, 2025 at 4:53 PM EDT

Hims & Hers (HIMS) Blows Out Earnings Expectations

Hims & Hers Health (NYSE:HIMS) reported a strong financial performance for Q1 2025, with revenue reaching $586 million, marking a…

Joel South | May 5, 2025 at 9:24 AM EDT

Hims & Hers (NYSE: HIMS) Earnings Are In (Live Coverage)

Hims & Hers Health (NYSE: HIMS) will report its Q1 2025 financial results today, after the market closes with a…

Joel South | Apr 29, 2025 at 9:58 AM EDT

S&P 500 (VOO) Live: Trump Administration Blasts Amazon.com, and the S&P 500 Tumbles

Stock markets opened lower on Tuesday, threatening to break the S&P 500’s five-day winning streak, although the market is moving…

Rich Duprey | Feb 25, 2025 at 12:41 PM EST

HIMS Stock Craters – Is It a Buying Opportunity?

Shares of Hims & Hers Health (NASDAQ:HIMS) continued to meltdown Tuesday in noontime trading after the direct-to-consumer healthcare platform said…

Gerelyn Terzo | Feb 25, 2025 at 10:24 AM EST

Markets Today: Dow Down, HD Rises, HIMS Sinks

The market’s attempts at gains have been denied in the face of weaker consumer confidence in February than had been…

Rich Duprey | Feb 24, 2025 at 12:36 PM EST

HIMS is Out. Is Novo Nordisk or Eli Lilly the Better GLP-1 Buy?

The Food & Drug Administration announced last week that the Ozempic and Wegovy shortage for Novo Nordisk‘s (NYSE:NVO | NVO…

Ian Cooper | Feb 21, 2025 at 11:47 AM EST

Hims & Hers (HIMS) Down 21% – Is the GLP-1 Gravy Train Over?

Shares of Hims & Hers Health (NYSE:HIMS) are down about 21%, or $14. All on news the Ozempic shortage is…

Gerelyn Terzo | Feb 19, 2025 at 11:38 AM EST

Live Markets: S&P 500 Reverses, NKLA Reels, HIMS Soars

The markets are trading lower with the S&P 500 retreating from its recently minted record high levels while the negative…

Joel South | Feb 7, 2025 at 12:53 PM EST

Why Hims & Hers Health (HIMS), Tempus AI (TEM) and Teladoc (TDOC) Are Up Big Today

Stock markets got a bit of a shock on Friday after a University of Michigan survey showed consumers are anticipating…

Rich Duprey | Jan 15, 2025 at 9:06 AM EST

Down 23%, Is This Dividend Giant a Buy After GLP-1 Sales Miss?

Next to artificial intelligence, weight-loss drugs have been one of the biggest themes investors latched onto in 2024. Eli Lilly…

Eric Bleeker | Jan 6, 2025 at 9:17 AM EST

Stock Market Today: Nasdaq Composite Up Big as NVIDIA and AI Stocks Rally

Stocks are running in premarket trading on Monday. Here’s a look at major indexes as of 8:50 a.m. ET: Nasdaq…

Rich Duprey | Sep 3, 2024 at 4:37 PM EDT

Has Eli Lilly Destroyed Hims & Hers Upside?

Capitalizing on the popularity of weight-loss drugs like Wegovy and Zepbound, Hims & Hers Health (NYSE:HIMS) has exploited a loophole…

1 2 3 4

Hims & Hers : HIMS

All Hims & Hers Articles

3 Stocks to 3X in 3 Years

3 Overlooked Dividend Growers With 10%+ Annual Dividend Increases

Buy Amazon (AMZN), Shopify (SHOP) and Hims & Hers (HIMS) in May And Hold Forever

Hims & Hers (HIMS) Blows Out Earnings Expectations

Hims & Hers (NYSE: HIMS) Earnings Are In (Live Coverage)

S&P 500 (VOO) Live: Trump Administration Blasts Amazon.com, and the S&P 500 Tumbles

HIMS Stock Craters – Is It a Buying Opportunity?

Markets Today: Dow Down, HD Rises, HIMS Sinks

HIMS is Out. Is Novo Nordisk or Eli Lilly the Better GLP-1 Buy?

Hims & Hers (HIMS) Down 21% – Is the GLP-1 Gravy Train Over?

Live Markets: S&P 500 Reverses, NKLA Reels, HIMS Soars

Why Hims & Hers Health (HIMS), Tempus AI (TEM) and Teladoc (TDOC) Are Up Big Today

Down 23%, Is This Dividend Giant a Buy After GLP-1 Sales Miss?

Stock Market Today: Nasdaq Composite Up Big as NVIDIA and AI Stocks Rally

Has Eli Lilly Destroyed Hims & Hers Upside?

This High-Yield ETF Combines Bond Investing With Emerging Market Currencies

SoFi Stock Could Jump 26% as Market Overreacts to One Soft Segment

China’s Semiconductor Equipment Companies Gain Share Despite U.S. Sanctions

52% of Americans Are Building Wealth While Ignoring Their Greatest Risk

3 Reasons Retirees Should Not Enroll in Medicare Advantage for 2026

This High-Yield ETF Combines Bond Investing With Emerging Market Currencies

SoFi Stock Could Jump 26% as Market Overreacts to One Soft Segment

Hims & Hers : HIMS

All Hims & Hers Articles

3 Stocks to 3X in 3 Years

3 Overlooked Dividend Growers With 10%+ Annual Dividend Increases

Buy Amazon (AMZN), Shopify (SHOP) and Hims & Hers (HIMS) in May And Hold Forever

Hims & Hers (HIMS) Blows Out Earnings Expectations

Hims & Hers (NYSE: HIMS) Earnings Are In (Live Coverage)

S&P 500 (VOO) Live: Trump Administration Blasts Amazon.com, and the S&P 500 Tumbles

HIMS Stock Craters – Is It a Buying Opportunity?

Markets Today: Dow Down, HD Rises, HIMS Sinks

HIMS is Out. Is Novo Nordisk or Eli Lilly the Better GLP-1 Buy?

Hims & Hers (HIMS) Down 21% – Is the GLP-1 Gravy Train Over?

Live Markets: S&P 500 Reverses, NKLA Reels, HIMS Soars

Why Hims & Hers Health (HIMS), Tempus AI (TEM) and Teladoc (TDOC) Are Up Big Today

Down 23%, Is This Dividend Giant a Buy After GLP-1 Sales Miss?

Stock Market Today: Nasdaq Composite Up Big as NVIDIA and AI Stocks Rally

Has Eli Lilly Destroyed Hims & Hers Upside?

This High-Yield ETF Combines Bond Investing With Emerging Market Currencies

SoFi Stock Could Jump 26% as Market Overreacts to One Soft Segment

China’s Semiconductor Equipment Companies Gain Share Despite U.S. Sanctions

Featured Reads

52% of Americans Are Building Wealth While Ignoring Their Greatest Risk

3 Reasons Retirees Should Not Enroll in Medicare Advantage for 2026